Both transmittals cover updates to the ASC payment rates for separately paid drugs and biologicals, as well as the six newly created HCPCS codes added to the list of covered ASC ancillary services, effective April 1, 2010.
Transmittal 1938, dated March 25, 2010, replaces Transmittal 1926, and adds the following two business requirements:
- Number 6866.5 — Contractors shall modify the procedure code file and TOS tables for HCPCS codes C9258, C9259, C9260, C9261, C9262, and C9263.
- Number 6866.6 — CWF shall assign TOS F for C9258, C9259, C9260, C9261, C9262, and C9263 for claims.
Transmittal 1943, dated April 6, 2010, adds the following short descriptions for the newly added HCPCS codes, effective April 1, 2010 (long descriptors in parentheses):
- HCPCS C9258 (Injection, telavancin, 10 mg) — Telavancin injection
- HCPCS C9259 (Injection, pralatrexate, 1 mg) — Pralatrexate injection
- HCPCS C9260 (Injection, ofatumumab, 10 mg) — Ofatumumab injection
- HCPCS C9261 (Injection, ustekinumab, 1 mg) — Ustekinumab injection
- HCPCS C9262 (Fludarabine phosphate, oral, 1 mg) — Fludarabine phosphate, oral
- HCPCS C9263 (Injection, ecallantide, 1 mg) — Ecallantide injection
Read CMS Transmittal 1938 (pdf).
Read CMS Transmittal 1943 (pdf).
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.